Topic of Histopathology Blinding in Nonclinical Safety Biomarker Qualification Studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Topic of Histopathology Blinding in Nonclinical Safety Biomarker Qualification Studies

Published:2010-06 Issue:4 Volume:38 Page:666-667
ISSN:0192-6233
Container-title:Toxicologic Pathology
language:en
Short-container-title:Toxicol Pathol

Author:

Burkhardt John E.¹,Ennulat Daniela²,Pandher Karamjeet³,Solter Phillip F.⁴,Troth Sean P.⁵,Boyce Rogely Waite⁶,Zabka Tanja S.⁷

Affiliation:

1. Abbott Laboratories, Abbott Park, IL

2. GlaxoSmithKline, King of Prussia, PA

3. Pfizer, Groton, CT

4. Department of Pathobiology, College of Veterinary Medicine, University of Illinois, Urbana, IL

5. Merck, West Point, PA

6. WIL Research Laboratories, Ashland, OH

7. Roche Pharmaceuticals, Nutley, NJ

Publisher

SAGE Publications

Subject

Cell Biology,Toxicology,Molecular Biology,Pathology and Forensic Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/0192623310371221

Reference7 articles.

1. Best Practices Guideline: Toxicologic Histopathology

2. Appropriateness of Methods for Slide Evaluation in the Practice of Toxicologic Pathology

3. Letter to the editor

4. Toxicity Testing: Some Principles and Some Pitfalls in Histopathological Evaluation

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Pathology: Applications in Nonclinical Drug Development;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024

2. Experimental Design and Statistical Analysis for Toxicologic Pathologists;Haschek and Rousseaux's Handbook of Toxicologic Pathology;2022

3. Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model;Journal of Antimicrobial Chemotherapy;2020-02-03

4. Urinary biomarker and histopathological evaluation of vancomycin and piperacillin-tazobactam nephrotoxicity in comparison with vancomycin in a rat model and a confirmatory cellular model;2019-03-06

5. Urinary biomarker evaluation for early detection of gentamycin-induced acute kidney injury;Toxicology Letters;2019-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3